If Teva ends up settling with the states, the dollar amount likely wouldn't be too big a burden, Credit Suisse analyst Vamil Divan, M.D., wrote in a Monday investor note.

Teva Pharmaceutical Industries will take a $315 million charge in its fourth quarter in connection with a settlement to resolve a drug-pricing lawsuit brought by Ven-A-Care of the Florida Keys against ...

Pfizer subsidiary Wyeth has agreed to pay $39 million to resolve claims from drug purchasers that it conspired with rival Teva to delay launching a less-expensive version of the antidepressant ...